Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease

被引:8
|
作者
Carnemolla, Sarah E. [1 ,2 ]
Kumfor, Fiona [1 ,2 ]
Liang, Cheng Tao [1 ,2 ]
Foxe, David [1 ,2 ]
Ahmed, Rebekah M. [2 ,3 ,4 ]
Piguet, Olivier [1 ,2 ]
机构
[1] Univ Sydney, Sch Psychol, Sydney, NSW, Australia
[2] Univ Sydney, Brain & Mind Ctr, 94 Mallett St, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Clin Neurosci, Memory & Cognit Clin, Sydney, NSW, Australia
[4] Univ Sydney, Cent Sydney Med Sch, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Alzheimer's disease; frontotemporal dementia; magnetic resonance imaging; neurodegeneration; olfaction; olfactory bulb; MILD COGNITIVE IMPAIRMENT; PROGRESSIVE NONFLUENT APHASIA; ANXIETY STRESS SCALES; ODOR IDENTIFICATION; BEHAVIORAL VARIANT; SEMANTIC DEMENTIA; MITRAL CELLS; VOLUME; SMELL; PREVALENCE;
D O I
10.3233/JAD-220080
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Olfactory dysfunction is highly prevalent in dementia syndromes, including Alzheimer's disease (AD) and frontotemporal dementia (FTD). The structural integrity of the olfactory bulb (OB) is thought to play a critical role in odor detection and identification, but no MRI study has measured OB volume in FTD, or measured OB volume longitudinally in AD. Objective: To measure OB volume in FTD and AD patients longitudinally using MRI. Methods: This study measured OB volumes using MRI in patients diagnosed with behavioral-variant FTD (n = 55), semantic dementia (n = 34), progressive non-fluent aphasia (n = 30), AD (n = 50), and healthy age-matched controls (n = 55) at their first visit to a dementia research clinic ('baseline'). Imaging data in patients 12-months later were analyzed where available (n = 84) for longitudinal assessment. Volumes of subcortical and cortical olfactory regions ('olfactory network') were obtained via surface-based morphometry. Results: Results revealed that in AD and FTD at baseline, OB volumes were similar to controls, whereas volumes of olfactory network regions were significantly reduced in all patient groups except in progressive non-fluent aphasia. Longitudinal data revealed that OB volume became significantly reduced (10-25% volume reduction) in all dementia groups with disease progression. Conclusion: Olfactory dysfunction is common in patients diagnosed with AD or FTD, but our results indicate that there is no detectable volume loss to the OBs upon first presentation to the clinic. Our findings indicate that the OBs become detectably atrophied later in the disease process. OB atrophy indicates the potential usefulness for OBs to be targeted in interventions to improve olfactory function.
引用
收藏
页码:51 / 66
页数:16
相关论文
共 50 条
  • [1] The olfactory bulb in Alzheimer’s disease
    Imre Kovács
    I. Török
    J. Zombori
    H. Yamaguchi
    Acta Biologica Hungarica, 1998, 49 (1): : 29 - 42
  • [2] The olfactory bulb in Alzheimer's disease
    Kovács, I
    Török, I
    Zombori, J
    Yamaguchi, H
    ACTA BIOLOGICA HUNGARICA, 1998, 49 (01): : 29 - 42
  • [3] Lateralized and Overall Olfactory Identification Ability in Frontotemporal Dementia and Alzheimer's Disease
    Heyanka, D.
    Golden, C.
    McCue, R.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2009, 24 (05) : 435 - 435
  • [4] In vivo and postmortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease
    Hornberger, Michael
    Wong, Stephanie
    Tan, Rachel
    Irish, Muireann
    Piguet, Olivier
    Kril, Jilian
    Hodges, John R.
    Halliday, Glenda
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 128 - 128
  • [5] Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration
    Luzzi, Simona
    Snowden, Julie S.
    Neary, David
    Coccia, Michela
    Provinciali, Leandro
    Ralph, Matthew A. Lambon
    NEUROPSYCHOLOGIA, 2007, 45 (08) : 1823 - 1831
  • [6] Pathology of the olfactory bulb in Alzheimer's disease
    Kovacs, T
    Cairns, NJ
    Lantos, PL
    BRAIN PATHOLOGY, 1997, 7 (04) : 1202 - 1202
  • [7] Presenilins in Alzheimer’s disease and frontotemporal dementia
    Jie Shen
    Molecular Neurodegeneration, 7 (Suppl 1)
  • [8] Empathy in frontotemporal dementia and Alzheimer's disease
    Fernandez-Duque, Diego
    Hodges, Sara D.
    Baird, Jodie A.
    Black, Sandra E.
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2010, 32 (03) : 289 - 298
  • [9] Epigenetics of Alzheimer's Disease and Frontotemporal Dementia
    Veerappan, Chendhore S.
    Sleiman, Sama
    Coppola, Giovanni
    NEUROTHERAPEUTICS, 2013, 10 (04) : 709 - 721
  • [10] Epigenetics of Alzheimer’s Disease and Frontotemporal Dementia
    Chendhore S. Veerappan
    Sama Sleiman
    Giovanni Coppola
    Neurotherapeutics, 2013, 10 : 709 - 721